Gilead Sciences GILD has outperformed the market over the past 20 years by 3.77% on an annualized basis producing an average ...

Gilead Sciences (GILD) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the ...

Finally, Kraft Heinz ( KHC 1.00%) rounds out the top three dividend payers on the Nasdaq 100. It's a household name in ...

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Just a few weeks after launching its Setting the P.A.C.E. initiative, Gilead Sciences is already picking up the tempo with a ...

Three stocks that are not only paying high yields but are also trading near their 52-week lows today are Starbucks ( SBUX ...

Gilead Sciences (GILD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Chris ...

Gilead Sciences Inc. CEO Daniel O'Day total compensation rose 4.6% year over year to $22.6 million as the expanding cancer and HIV drug maker's median employee compensation dipped 15%. The ...

Gilead Sciences with World Hepatitis Alliance to award US$ 4 mn ALL4LIVER grant for viral hepatitis elimination by 2030 ...

Life-science company planners and medical-society planners reveal the critical issues they contend with when working on ...

In anticipation of the state coming to inspect the town’s transfer station, Town Clerk Patsy Cox said she was relieved that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...